The objective was to cater to the growing refractories demand of the country emerging out of growth in ferrous, non-ferrous, cement, petrochemicals and chemical industries. The company made its ...

RHI Magnesita India Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 11,871.77 Crore) operating in Industrial Consumables sector. RHI Magnesita India Ltd. key ...

(RTTNews) - Syndax Pharmaceuticals, Inc. (SNDX), Tuesday announced positive results from the relapsed or refractory mutant NPM1 acute myeloid leukemia cohort in the pivotal Phase 2 portion of the ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced positive topline results from the relapsed or ...

During November, 1983, the name of the company was changed to the present one. The Main objects is to manufacture and deal in refractories, stoneware, spun pipes, red-oxide powder, potassium chlorate.

NILACHAL REFRACTORIES LTD. - Board Meeting Intimation for Board Meeting Is Scheduled To Declared 2Nd Quarter For Financial 2024-25.

(Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated ... Phase 2 NAVAL-1 trial of Nana-val (nanatinostat in combination with ...

Dividend announcements are not available. No other corporate actions details are available.

Eric Easom, the company's co-founder, chairman, president and chief executive officer, said recent data analysis indicate that epetraborole may provide clinical improvement in patients with ...